Region:Middle East
Author(s):Geetanshi
Product Code:KRAC2314
Pages:86
Published On:October 2025
By Type:The multiomics services market can be segmented into various types, including genomics, proteomics, metabolomics, transcriptomics, epigenomics, pharmacogenomics, and others. Among these,genomicsis currently the leading sub-segment due to its extensive application in personalized medicine and drug development. The increasing prevalence of genetic disorders and the demand for tailored therapies are driving the growth of genomics services.Proteomicsandmetabolomicsare also gaining traction, particularly in biomarker discovery and disease diagnosis, supported by technological advancements in sequencing and mass spectrometry .
By End-User:The end-user segmentation includes academic research institutions, pharmaceutical companies, clinical laboratories, biotechnology firms, hospitals and healthcare providers, and others.Pharmaceutical companiesare the dominant end-user segment, driven by the need for advanced research in drug development and personalized medicine. Academic institutions also play a crucial role in driving innovation and research in multiomics, while clinical laboratories are increasingly adopting these technologies for diagnostic purposes. The growing collaboration between industry and academia is further accelerating the adoption of multiomics services in Saudi Arabia .
The Saudi Arabia Multiomics Services Market is characterized by a dynamic mix of regional and international players. Leading participants such as Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN N.V., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., PerkinElmer, Inc., BGI Genomics Co., Ltd., Roche Holding AG, Merck KGaA, Genomatix Software GmbH, 10X Genomics, Inc., Eurofins Scientific SE, Ginkgo Bioworks, Inc., Zymo Research Corporation, CENTOGENE contribute to innovation, geographic expansion, and service delivery in this space.
The future of the multiomics services market in Saudi Arabia appears promising, driven by ongoing investments in healthcare innovation and technology. In future, the government is expected to allocate SAR 2 billion towards biotechnology research, fostering collaborations between local and international firms. Additionally, the increasing focus on preventive healthcare will likely enhance the adoption of multiomics services, enabling early disease detection and personalized treatment plans that cater to the unique genetic makeup of the population.
| Segment | Sub-Segments |
|---|---|
| By Type | Genomics Proteomics Metabolomics Transcriptomics Epigenomics Pharmacogenomics Others |
| By End-User | Academic Research Institutions Pharmaceutical Companies Clinical Laboratories Biotechnology Firms Hospitals and Healthcare Providers Others |
| By Application | Drug Discovery Disease Diagnosis Biomarker Discovery Personalized Medicine Nutrigenomics Others |
| By Service Type | Data Analysis Services Sample Preparation Services Consulting Services Laboratory Services Others |
| By Technology | Next-Generation Sequencing Mass Spectrometry Microarray Technology Bioinformatics Others |
| By Distribution Channel | Direct Sales Online Sales Distributors Others |
| By Pricing Model | Subscription-Based Pay-Per-Use Project-Based Others |
| Scope Item/Segment | Sample Size | Target Respondent Profiles |
|---|---|---|
| Oncology Multiomics Services | 85 | Oncologists, Clinical Researchers |
| Cardiovascular Genomics | 65 | Cardiologists, Genetic Counselors |
| Rare Disease Diagnostics | 55 | Healthcare Providers, Laboratory Directors |
| Pharmacogenomics Applications | 50 | Pharmacists, Clinical Pharmacologists |
| Research and Development in Multiomics | 75 | Biotech Researchers, Lab Managers |
The Saudi Arabia Multiomics Services Market is valued at approximately USD 17 million, driven by advancements in biotechnology, healthcare infrastructure investments, and the rising demand for personalized medicine.
What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.
